Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 11855
TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653576(US20240059728, Example 2 | 3-[4-(4-Chloro-3,5-difl...)
Affinity DataKd:  0.300nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653575(3,3′-Dideoxy-3-[4-(3,4,5-trifluorophenyl)-1H...)
Affinity DataKd:  0.400nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653577(US20240059728, Example 3 | 3′-[4-(2-Aminothi...)
Affinity DataKd:  1nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653575(3,3′-Dideoxy-3-[4-(3,4,5-trifluorophenyl)-1H...)
Affinity DataKd:  3nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653576(US20240059728, Example 2 | 3-[4-(4-Chloro-3,5-difl...)
Affinity DataKd:  4nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653579(US20240059728, Example 5 | 1,1′-Sulfanediyl-...)
Affinity DataKd:  6nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653577(US20240059728, Example 3 | 3′-[4-(2-Aminothi...)
Affinity DataKd:  9nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653578(US20240059728, Example 4 | 1,1′-Sulfanediyl-...)
Affinity DataKd: <10nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653580(US20240059728, Example 14 | 1,1'-Sulfanediyl-bis- ...)
Affinity DataKd:  12nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653580(US20240059728, Example 14 | 1,1'-Sulfanediyl-bis- ...)
Affinity DataKd:  450nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653578(US20240059728, Example 4 | 1,1′-Sulfanediyl-...)
Affinity DataKd:  780nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM653579(US20240059728, Example 5 | 1,1′-Sulfanediyl-...)
Affinity DataKd:  890nMAssay Description:The affinity of Example 1-14 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
Go to US Patent